ChinaBio Today -- Last week in China biotech, the flood of quarterly earnings reports slowed from the previous week’s frenetic pace, and normal business news – financings, JV agreements, new products – moved to fill in the space. From our perhaps biased view here at ChinaBio® Today, one of the most significant announcements last week came from our sister organization, ChinaBio® Accelerator, which announced it will hold the ChinaBio® Partnering Forum on June 3 and 4, 2009 in Shanghai (see story). The event, the first partnering forum focused on China life science technology to be held in China, will bring together more than 300 attendees seeking partnership deals. Universities, institutes and companies from throughout China, representing nearly 100 novel technologies, will have the opportunity to meet potential partners. The potential partners will include nearly all the major pharma companies, many of China’s own pharma, biotech and medical device companies, 50+ VCs, and many others interested in licensing or commercializing novel technologies. The two-day forum will feature one-on-one partnering meetings, technology presentations by China-based researchers and biotech companies, big pharma discussions of their “wish lists,” executive workshops and exhibits.
